Teva - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Teva’s Ajovy meets goals in Phase II/III trials in Japan

Teva licensed Ajovy Japanese rights to development and sale to Otsuka. Credit: Open Grid Scheduler / Grid Engine.